We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Skin Tests to Predict Antibiotic Allergies May Be Useless

By HospiMedica International staff writers
Posted on 26 Apr 2016
Oral provocation challenge (PC), with appropriate follow up, is more efficient and safer for screening non-life threatening reactions to amoxicillin in children than skin tests, according to a new study.

Researchers at McGill University Health Center (MUHC; Montreal, QC, Canada) conducted a cohort study among 818 children (median age 1.7 years) referred to Montreal Children’s Hospital (QC, Canada) between March 1, 2012, and April 1, 2015, with suspected allergy to amoxicillin, in order to assess the accuracy and the negative predictive value of an oral PC. More...
In addition, 346 of the eligible children were followed up to assess reactions to subsequent use of amoxicillin in cases with negative PC results.

The results showed that 94.1% of the children tolerated the PC, with only 17 of the children having an immediate positive reaction to amoxicillin, and only one within this group with a positive graded PC. This represents a specificity of 100%, a negative predictive value of 89.1%, and a positive predictive value of 100%. Additionally, among 250 participants who responded to annual follow-up and 55 who received treatment, 89.1% reported tolerance to subsequent full treatment with amoxicillin, while 10.9% developed non-immediate cutaneous reactions. The study was published on April 4, 2016, in JAMA Pediatrics.

“Our study suggests that skin tests are essentially useless as diagnostic tests, and that we should go directly to the graded provocation test that is highly sensitive and specific,” said lead author allergologist Moshe Ben-Shoshan, MD, an assistant professor of Pediatrics at McGill University. “This is a game changer in the way physicians assess amoxicillin allergy in children, given the fact that skin tests are still the recommended screening method in hospitals.”

Amoxicillin is an antibiotic that first became available in 1972, and is on the World Health Organization (WHO) List of Essential Medicines it is one of the most commonly prescribed antibiotics in children; common side effects include nausea and rash. It may also increase the risk of yeast infections and, when used in combination with clavulanic acid, diarrhea. Up to 10% of children show a late-developing rash, sometimes referred to as the amoxicillin rash, which starts on the trunk and can spread from there. This rash is unlikely to be a true allergic reaction, and is not a contraindication for future amoxicillin usage.

Related Links:
McGill University Health Center
Montreal Children’s Hospital

Gold Member
12-Channel ECG
CM1200B
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Desk Aneroid Sphyg
Diagnostix 750D+
New
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.